Competitive Analysis of the Global Opioid Therapeutics Market

Opportunities Exist for Tamper-resistant Formulations

Regular Price: USD 4,950

Special Price USD 4,208

15% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,208

PAY BY INVOICE

Be the first to review this product

This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development. The information contained in this research service was derived from published sources including the following: disease organization Web sites; Frost & Sullivan publications, including annual reports; Securities and Exchange Commission (SEC) filings and press releases; United States government public sources; and scientific journals.

Table of Contents

Competitive Analysis of the Global Opioid Therapeutics Market, Global Opioid Therapeutics MarketGlobal Opioid Therapeutics Analysis of the Global Opioid Therapeutics Market




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Asia Pacific

Release Date : 06-Dec-17

Region : Asia Pacific

Release Date : 27-Nov-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.